Read + Share
Oikonomopoulou C, Goussetis E. HSCT remains the only cure for patients with transfusion-dependent thalassemia
until gene therapy strategies are proven to be safe. Bone Marrow Transplant 2021;56:2882-2888.
PMID: 34531544
|
 |
|
Oikonomopoulou C, Goussetis E. HSCT remains the only cure for patients with transfusion-dependent thalassemia
until gene therapy strategies are proven to be safe. Bone Marrow Transplant 2021;56:2882-2888.
PMID: 34531544
|
|
|
|